Franklin Resources’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-44,975
Closed -$804K 3356
2026
Q1
$804K Sell
44,975
-223,640
-83% -$4.89M ﹤0.01% 2270
2025
Q4
$7.25M Buy
268,615
+51,651
+24% +$1.45M ﹤0.01% 1263
2025
Q3
$6.56M Sell
216,964
-310,075
-59% -$9.89M ﹤0.01% 1326
2025
Q2
$14.1M Buy
+527,039
New +$14.2M ﹤0.01% 1027

Other funds holding CAI

Franklin Resources's CAI Position: Q2 2026 in Review

Franklin Resources sold out of Caris Life Sciences (CAI) in Q2 2026, closing a stake of 44,975 shares — an estimated $804K sold.

Franklin Resources first reported a position in CAI in Q2 2025 and held it in 4 quarters. The position peaked at $14.1M in Q2 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Franklin Resources reported no remaining Caris Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Franklin Resources sold 44,975 Caris Life Sciences shares in Q2 2026, an estimated $804K.
  • Franklin Resources first reported a position in Caris Life Sciences in Q2 2025 and held it in 4 quarters.
  • Franklin Resources's Caris Life Sciences position peaked at $14.1M in Q2 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.